GSK2838232
GSK2838232 inhibit HIV reverse transcriptase activity across a broad panel of HIV-1 isolates, extracted from patent WO/2013090664A1, compound51.
Product Specifications
CAS Number
[1443460-91-0]
UNSPSC
12352005
Target
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/GSK2838232.html
Purity
98.99
Solubility
DMSO : ≥ 50 mg/mL
Smiles
CC1(C)[C@@H](OC(CC(C)(C)C(O)=O)=O)CC[C@@]2(C)[C@@]1([H])CC[C@]3(C)[C@]2([H])CC[C@@]4([H])[C@@]3(C)CC[C@](C5)([C@H](CN(CCN(C)C)CC6=CC=C(Cl)C=C6)O)C4=C(C(C)C)C5=O
Molecular Formula
C48H73ClN2O6
Molecular Weight
809.56
References & Citations
[1]Hatcher Mark Andrew, et al. Preparation of betulin derivatives for the treatment of HIV. From PCT Int. Appl. (2013), WO 2013090664 A1 20130620.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
HIV-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
040580-HRP 200 µL
PSTPIP1, NT (PSTPIP1, CD2BP1, Proline-serine-threonine phosphatase-interacting protein 1, CD2-binding protein 1, H-PIP) (Azide free) (HRP) discontinued
Ask
View Details 
